Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-03

Clinical Trial Update: Short Interval Resveratrol Trial in Cardiovascular Surgery [NA]

View source ↗

Summary

A clinical trial evaluating resveratrol in patients with Type 2 diabetes mellitus and coronary artery disease undergoing cardiovascular surgery; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: MaineHealth | Conditions: Diabetes Mellitus, Type 2, Coronary Artery Disease | NA | Status: ACTIVE_NOT_RECRUITING